Interestingly, and similar to what we have observed, an imbalance in C1P and S1P availability is also critical in the progression of other diseases, such as glioblastoma49, acute lung injury50,51, Parkinson’s disease52, pancreatic cancer cells53, and chronic inflammatory processes54,55. This evidence concerns the gene MBTPS1 and familial pancreatic carcinoma.